Skip to main content
. 2021 May 15;99(7):skab156. doi: 10.1093/jas/skab156

Table 1.

Conical pathway expression between Con and 100 ng LPS treatments

Function Pathways Fold change (−log P-value)1 Z-score2
Cell biosynthesis and turnover IGF-1 2.9 0.707
EGF 2.6 0.816
ErbB2-ErbB3 2.24 −0.447
ILK 2.05 1
cAMP 1.88 −0.302
PI3K 1.63 1.414
ERK5 1.46 1.342
Ceramide 0.848 1.89
Nucleic modification Unfolded protein 5.93 0.378
Telomerase 3.43 0.707
HMGB1 2.5 1.414
EIF2 1.94 0.333
Neurotrophin/TRK 1.91 0.816
JAK/Stat 1.81 0.816
Oxidative response/autophagy NRF2 oxidative stress resp. 6.48 1.265
IL-6 3.49 −0.905
p38 MAPK 3.09 1
Sumoylation 2.35 1.633
TNFR-2 2.19 2
CXCR4 2.01 0.707
IL-8 1.52 0.632
NO/ROS prod. In Macrophages 1.31 0.333
IL-3 1.31 1.342
Muscle function oxidative stress eNOS signaling 2.63 −2.121
Agrin 1.84 1.342
Calcium signaling 1.81 −1.633
PPARα/RXRα 1.65 −1.265
D-myo-inositol-tetrakiphosphate 1.59 0.707

1Pathway expressions are statistically significant (P < 0.05). 2Numerical values denote degree of z-score (positive = upregulated to 100 ng LPS; negative = upregulated to Con) and gross fold change (−log P-value).